EUVIMEDOpdag EUVIMED
Crossref

When Fetal Anomalies Lead to Prognostic Clarification: An Underrecognized Application of Exome Sequencing

Jonathan Rips iD, Hagar Mor-Shaked iD, Rivka Birnbaum, Avital Eilat, Natalie Goldwicht, Shay Porat iD, Uri Erlik, Lilach Benyamini, Hagit Daum iD

Prenatal Diagnosis · 2026

DOI: 10.1002/pd.70239 ↗

At a glance

Journal article in Prenatal Diagnosis, 2026. Written by Jonathan Rips and 8 co-authors. Institution: Department of Genetics, Hadassah Medical Center, Jerusalem, Israel. Major MEDLINE topics: Exome Sequencing, Prenatal Diagnosis, Fetus, Congenital Abnormalities. 25 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Objectives

To describe a cohort of fetuses with abnormal prenatal findings in whom exome sequencing (ES) identified genetic diagnoses that refined prognostic assessment and reduced prognostic uncertainty.

Methods

We retrospectively reviewed all fetal ES studies performed at our center between 2017 and 2025 for structural or biochemical abnormalities. Cases with a definitive molecular diagnosis were identified, and those with predicted mild, isolated, transient, or treatable phenotypes were classified as having comparatively favorable prognostic implications. Clinical findings and expected postnatal outcomes were analyzed.

Results

Among 1692 fetuses undergoing ES, a molecular diagnosis was identified in 291 (17%). Of these, five cases (∼2%) were considered reassuring: isolated postaxial polydactyly due to a GLI1 variant; X‐linked ichthyosis (STS) in a fetus with low estriol; isolated situs inversus; CFAP52‐related situs inversus totalis; and MAGED2‐associated transient antenatal Bartter syndrome. In all cases, ES refined prognosis and reduced the likelihood of severe syndromic conditions, enabling clearer counseling.

Conclusions

Beyond detecting severe disorders, ES may help distinguish mild or manageable conditions from complex syndromes. In selected cases, it provides meaningful reassurance, reduces uncertainty, and supports informed prenatal decision‐making.

Subjects

MeSH terms (MEDLINE)

Exome SequencingPrenatal DiagnosisFetusCongenital AbnormalitiesHumansFemalePrognosisPregnancyRetrospective StudiesAdult

Author keywords

fetal structural anomaliesgenetic counselingmolecular diagnosispregnancy managementprenatal exome sequencingprognosis

Authors and institutions

  • Department of Genetics, Hadassah Medical Center, Jerusalem, Israel.
  • Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Obstetrics and Gynecology, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Maayane Hayeshua Medical Center, Gray Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Genetic Institute, Shamir Medical Center (Assaf Harofe), Gray Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

ORCID profiles: Jonathan Rips, Hagar Mor-Shaked, Shay Porat, Hagit Daum

Cite

APA

Rips, J., Mor-Shaked, H., Birnbaum, R., Eilat, A., Goldwicht, N., Porat, S., Erlik, U., Benyamini, L., & Daum, H. (2026). When Fetal Anomalies Lead to Prognostic Clarification: An Underrecognized Application of Exome Sequencing. Prenatal Diagnosis. https://doi.org/10.1002/pd.70239

Vancouver

Rips J, Mor-Shaked H, Birnbaum R, Eilat A, Goldwicht N, Porat S, et al. When Fetal Anomalies Lead to Prognostic Clarification: An Underrecognized Application of Exome Sequencing. Prenatal Diagnosis. 2026. doi:10.1002/pd.70239

BibTeX
@article{Rips2026,
  author = {Rips, Jonathan and Mor-Shaked, Hagar and Birnbaum, Rivka and Eilat, Avital and Goldwicht, Natalie and Porat, Shay and Erlik, Uri and Benyamini, Lilach and Daum, Hagit},
  title = {When Fetal Anomalies Lead to Prognostic Clarification: An Underrecognized Application of Exome Sequencing},
  journal = {Prenatal Diagnosis},
  year = {2026},
  doi = {10.1002/pd.70239}
}
Start for free →